Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are
common clinical problems in urology. While the precise molecular etiology remains unclear …

Estrogens and androgens have both been implicated as causes of benign prostatic
hyperplasia (BPH). Although epidemiological data on an association between serum …

OBJECTIVE The potential use of testosterone preparations for substitution therapy for
ageing men and for male contraception, In addition to the well established substitution …

Benign prostate hyperplasia (BPH) is a major cause of lower urinary tract symptoms, with an
increased volume of transitional zone and associated with increased stromal cells. It is …

Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are androgen-dependent
diseases commonly treated by inhibiting androgen action. However, androgen ablation or …

Benign prostatic hyperplasia is a nonmalignant enlargement of the prostate that is due to
excessive cellular growth of both the glandular and the stromal elements of the gland. The …

The decrease in testosterone levels with age is both central (pituitary) and peripheral
(testicular) origin. Because serum levels of sex-hormone-binding globulin increase with …

Castration of adult male rats reduces by half the penile erectile response to electrical field
stimulation (EFS) of the cavernosal nerve, and the activity of penile nitric oxide synthase …

Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract
symptoms in men. Current treatments target prostate physiology rather than BPH …

Benign prostatic hyperplasia (BPH) is an age-related disease of the urinary system that
affects elderly men. Current treatments for BPH are associated with several adverse effects …